ROYAL BANK OF CANADA - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 24 filers reported holding ELIEM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$5,000686
+988.9%
0.00%
Q1 2024$063
+75.0%
0.00%
Q4 2023$036
-35.7%
0.00%
Q3 2023$056
-55.2%
0.00%
Q2 2023$0125
+12.6%
0.00%
Q3 2022$0111
+296.4%
0.00%
Q2 2022$0
-100.0%
28
-92.4%
0.00%
Q1 2022$3,000
-82.4%
370
-76.9%
0.00%
Q4 2021$17,000
+21.4%
1,603
+105.5%
0.00%
Q3 2021$14,0007800.00%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
RA Capital Management 13,150,849$236,452,0003.28%
Monashee Investment Management LLC 305,233$5,488,0001.01%
SAMLYN CAPITAL, LLC 1,681,025$30,225,0000.40%
Woodline Partners LP 387,224$6,962,0000.11%
TUDOR INVESTMENT CORP ET AL 287,294$5,166,0000.08%
CAAS CAPITAL MANAGEMENT LP 75,000$1,349,0000.03%
Hudson Bay Capital Management LP 100,000$1,798,0000.02%
GOLDMAN SACHS GROUP INC 165,952$2,984,0000.00%
HRT FINANCIAL LP 11,797$212,0000.00%
MILLENNIUM MANAGEMENT LLC 71,983$1,294,0000.00%
View complete list of ELIEM THERAPEUTICS INC shareholders